Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ATX101 |
Trade Name | |
Synonyms | ATX-101|ATX 101 |
Drug Descriptions |
ATX101 is a peptide that targets PCNA, leading to decreased PCNA expression and inhibition of Akt and mTORC signaling, and potentially resulting in reduced tumor cell proliferation and inhibition of tumor growth (PMID: 35053455). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C180525 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ATX101 | ATX101 | 0 | 1 |
ATX101 + Carboplatin + Pegylated liposomal doxorubicin | ATX101 Carboplatin Pegylated liposomal doxorubicin | 0 | 1 |